Springer Jr C, Pike M, Barbara T
J Membr Biol. 2025; .
PMID: 40009106
DOI: 10.1007/s00232-024-00332-1.
Mudgal D, Yadav N, Srivastava G, Mishra M, Mishra V
Curr Pharm Des. 2024; 31(4):261-291.
PMID: 39410885
DOI: 10.2174/0113816128310031240923062555.
Springer Jr C, Pike M, Barbara T
bioRxiv. 2024; .
PMID: 38659823
PMC: 11042311.
DOI: 10.1101/2024.04.17.589812.
Qiu Y, Gao Y, Huang B, Bai Q, Zhao Y
Nat Struct Mol Biol. 2024; 31(4):701-709.
PMID: 38589607
DOI: 10.1038/s41594-024-01259-w.
Castoldi G, Carletti R, Barzaghi F, Meani M, Zatti G, Perseghin G
Pharmaceuticals (Basel). 2024; 17(3).
PMID: 38543148
PMC: 10975335.
DOI: 10.3390/ph17030362.
Ion and lipid orchestration of secondary active transport.
Drew D, Boudker O
Nature. 2024; 626(8001):963-974.
PMID: 38418916
DOI: 10.1038/s41586-024-07062-3.
Transport and inhibition mechanism of the human SGLT2-MAP17 glucose transporter.
Hiraizumi M, Akashi T, Murasaki K, Kishida H, Kumanomidou T, Torimoto N
Nat Struct Mol Biol. 2023; 31(1):159-169.
PMID: 38057552
PMC: 10803289.
DOI: 10.1038/s41594-023-01134-0.
Membrane potential accelerates sugar uptake by stabilizing the outward facing conformation of the Na/glucose symporter vSGLT.
Khan F, Elgeti M, Grandfield S, Paz A, Naughton F, Marcoline F
Nat Commun. 2023; 14(1):7511.
PMID: 37980423
PMC: 10657379.
DOI: 10.1038/s41467-023-43119-z.
Influence of SGLT1 Sugar Uptake Inhibitors on Water Transport.
Sever M, Merzel F
Molecules. 2023; 28(14).
PMID: 37513169
PMC: 10385929.
DOI: 10.3390/molecules28145295.
Collective Domain Motion Facilitates Water Transport in SGLT1.
Sever M, Merzel F
Int J Mol Sci. 2023; 24(13).
PMID: 37445706
PMC: 10342062.
DOI: 10.3390/ijms241310528.
Structures of human SGLT in the occluded state reveal conformational changes during sugar transport.
Cui W, Niu Y, Sun Z, Liu R, Chen L
Nat Commun. 2023; 14(1):2920.
PMID: 37217492
PMC: 10203128.
DOI: 10.1038/s41467-023-38720-1.
Use of Animal Models for Investigating Cardioprotective Roles of SGLT2 Inhibitors.
Al Thani N, Hasan M, Yalcin H
J Cardiovasc Transl Res. 2023; 16(5):975-986.
PMID: 37052784
PMC: 10615955.
DOI: 10.1007/s12265-023-10379-5.
Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling.
Ding L, Chen X, Zhang W, Dai X, Guo H, Pan X
J Clin Invest. 2023; 133(1).
PMID: 36594471
PMC: 9797339.
DOI: 10.1172/JCI154754.
Structural mechanism of SGLT1 inhibitors.
Niu Y, Cui W, Liu R, Wang S, Ke H, Lei X
Nat Commun. 2022; 13(1):6440.
PMID: 36307403
PMC: 9616851.
DOI: 10.1038/s41467-022-33421-7.
Sodium-Glucose Cotransporter Inhibitors as Antidiabetic Drugs: Current Development and Future Perspectives.
Maccari R, Ottana R
J Med Chem. 2022; 65(16):10848-10881.
PMID: 35924548
PMC: 9937539.
DOI: 10.1021/acs.jmedchem.2c00867.
Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models.
Feijoo-Bandin S, Aragon-Herrera A, Otero-Santiago M, Anido-Varela L, Morana-Fernandez S, Tarazon E
Int J Mol Sci. 2022; 23(10).
PMID: 35628443
PMC: 9144929.
DOI: 10.3390/ijms23105634.
Alterations of sodium-hydrogen exchanger 1 function in response to SGLT2 inhibitors: what is the evidence?.
Wichaiyo S, Saengklub N
Heart Fail Rev. 2022; 27(6):1973-1990.
PMID: 35179683
DOI: 10.1007/s10741-022-10220-2.
Structure and mechanism of the SGLT family of glucose transporters.
Han L, Qu Q, Aydin D, Panova O, Robertson M, Xu Y
Nature. 2021; 601(7892):274-279.
PMID: 34880492
PMC: 9482448.
DOI: 10.1038/s41586-021-04211-w.
The Molecular Basis of Glucose Galactose Malabsorption in a Large Swedish Pedigree.
Lostao M, Loo D, Hernell O, Meeuwisse G, Martin M, Wright E
Function (Oxf). 2021; 2(5):zqab040.
PMID: 34485913
PMC: 8410129.
DOI: 10.1093/function/zqab040.
Function Trumps Form in Two Sugar Symporters, and .
Abramson J, Wright E
Int J Mol Sci. 2021; 22(7).
PMID: 33808202
PMC: 8037263.
DOI: 10.3390/ijms22073572.